| |
| |
|
| Insider
Information: |
Tanguler Tolga |
| Relationship: |
EVP, Chief Commercial ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
9,987 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,497,651 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
9,987 |
|
|
| Total
Value |
$1,497,651 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
EVP, Chief Commercial ... |
2024-03-01 |
9,987 |
2022-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,751 |
9,987 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2024-02-28 |
4 |
S |
$154.54 |
$77,805 |
D/D |
(501) |
5,236 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2024-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,667 |
5,737 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2024-02-16 |
4 |
S |
$147.50 |
$149,397 |
D/D |
(1,009) |
4,070 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,278 |
5,079 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2023-04-27 |
4 |
S |
$193.18 |
$287,215 |
D/D |
(1,476) |
1,801 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2023-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,277 |
3,277 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2023-02-03 |
4 |
AS |
$227.68 |
$794,854 |
D/D |
(3,424) |
0 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2023-02-02 |
4 |
AS |
$223.97 |
$361,839 |
D/D |
(1,601) |
3,424 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2023-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,025 |
5,025 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2022-08-05 |
4 |
AS |
$215.03 |
$401,630 |
D/D |
(1,841) |
0 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2022-08-04 |
4 |
D |
$189.76 |
$342,817 |
D/D |
(1,788) |
1,841 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2022-08-03 |
4 |
AS |
$210.00 |
$368,340 |
D/D |
(1,754) |
3,629 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2022-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,629 |
5,383 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2022-07-05 |
4 |
AS |
$150.00 |
$263,100 |
D/D |
(1,754) |
1,754 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2022-02-02 |
4 |
D |
$144.67 |
$219,609 |
D/D |
(1,518) |
3,508 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Commercial Officer |
• – – |
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,026 |
5,026 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
